LivaNova (LIVN) Change in Accured Expenses (2015 - 2026)
LivaNova (LIVN) posted Change in Accured Expenses of -$38.8 million for Q1 2026, down 271.52% sequentially from $22.6 million in Q4 2025, and down 27.05% YoY from -$53.1 million in Q1 2025.
LivaNova (LIVN) Change in Accured Expenses (2015 - 2026) Analysis & Trends
LivaNova has reported Change in Accured Expenses for 12 years, with the latest figure at -$38.8 million in Q1 2026.
- Quarterly Change in Accured Expenses fell 27.05% year-over-year to -$38.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$21.7 million (up 26.23% YoY) and the FY2025 annual result came in at -$13.4 million, up 7.13% from the prior year.
- Change in Accured Expenses slipped to -$38.8 million in Q1 2026 per LIVN's latest filing, from $22.6 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $27.3 million in Q4 2023 and troughed at -$38.8 million in Q1 2026.
- A 5-year average of -$3.0 million and a median of -$2.7 million in 2025 frame the typical range for Change in Accured Expenses.
- The widest YoY moves for Change in Accured Expenses: up 2603.04% in 2022, down 641.8% in 2022.
- Over 5 years, Change in Accured Expenses stood at $1.9 million in 2022, then jumped by 1346.9% to $27.3 million in 2023, then slumped by 67.35% to $8.9 million in 2024, then jumped by 153.85% to $22.6 million in 2025, then slumped by 271.52% to -$38.8 million in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered -$38.8 million, $22.6 million, and -$2.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.91 Bn | 193.31 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.59 Bn | 124.11 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 73.24 Bn | 72.70 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 34.38 Bn | 32.44 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.96 Bn | 31.85 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.08 Bn | 22.60 Bn | 684.20 Mn | 4.80 Mn |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn | 6.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.06 Mn |
| Jun 30, 2026 | 6.06 Mn |
| Mar 31, 2026 | -38.77 Mn |
| Mar 31, 2026 | -38.77 Mn |
| Dec 31, 2025 | 22.61 Mn |
| Dec 31, 2025 | 22.61 Mn |
| Sep 30, 2025 | -2.88 Mn |
| Sep 30, 2025 | -2.88 Mn |
| Jun 30, 2025 | -2.66 Mn |
| Jun 30, 2025 | -2.66 Mn |
| Mar 31, 2025 | -30.52 Mn |
| Mar 31, 2025 | -30.52 Mn |
| Dec 31, 2024 | 8.91 Mn |
| Dec 31, 2024 | 8.91 Mn |
| Sep 30, 2024 | 2.00 Mn |
| Sep 30, 2024 | 2.00 Mn |
| Jun 30, 2024 | -9.80 Mn |
| Jun 30, 2024 | -9.80 Mn |
| Mar 31, 2024 | -15.58 Mn |
| Mar 31, 2024 | -15.58 Mn |